Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

‘Killer’ cells used to combat rare cancer

10.09.2002


Scientists from the University of Edinburgh are using immune cells harvested from blood donors to help fight an unusual cancer which can affect transplant patients. And their findings, published recently in The Lancet show that the therapy has proved effective in a number of cases. The treatment proved successful last year in saving the life of a four-year-old boy from Birmingham, who developed the cancer— post-transplant lympho-proliferative disease— following a liver and bowel transplant.



The technique, which involves boosting the patient’s own immune system to fight cancer without affecting the transplanted organ, can also be adapted to treat other virus infections, or AIDS patients who have developed lymphomas.

Clinical research scientist Dr Tanzina Haque explained: “The Epstein-Barr virus (EBV) is a common virus best known for causing glandular fever, and is carried by about 90% of the population, without a problem. When a patient receives an organ transplant, he or she is given immuno-suppressive drugs to stop the body rejecting the organ, but this also lowers their immunity to infections by removing the body’s ’killer’ cells, the cytotoxic T-lymphocytes. If a transplant patient’s immunity is compromised, EBV can infect cells called B-lymphocytes, causing them to grow in an uncontrolled way and become malignant. The resulting cancer can be fatal in up to 70% of cases.”


Dr Haque said that to reduce doses of immuno-suppressive drugs could cause organ transplant rejection, so the Edinburgh team, headed by Professor Dorothy Crawford and backed by funding from Cancer Research UK, devised a method of removing ‘killer’ cells from screened blood donations and tissue-type matching them to transplant patients. Should any patients develop lymphoma, they can be infused with matched cells from the bank containing more than 100 blood donations.

The technique, known as Cytotoxic T-Lymphocyte (CTL) Therapy, has shown to have no adverse side-effects for patients. Results published in The Lancet show of eight patients in the trial who were suitable for treatment, two died, five made a complete recovery, two did not respond and one showed a partial response. Two further patients died before their tumour response could be evaluated.

Dr Haque said this UK-wide multicentre clinical trial could not have been possible without the collaboration of the Scottish National Blood Transfusion Service, different transplant centers, and the many blood donors who helped by allowing their blood to be used for generating the T-cells.

Linda Menzies | alfa
Further information:
http://www.ed.ac.uk/news/

More articles from Health and Medicine:

nachricht New way to target advanced breast cancers
24.09.2018 | Jackson Laboratory

nachricht Neutrons produce first direct 3D maps of water during cell membrane fusion
21.09.2018 | DOE/Oak Ridge National Laboratory

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists present new observations to understand the phase transition in quantum chromodynamics

The building blocks of matter in our universe were formed in the first 10 microseconds of its existence, according to the currently accepted scientific picture. After the Big Bang about 13.7 billion years ago, matter consisted mainly of quarks and gluons, two types of elementary particles whose interactions are governed by quantum chromodynamics (QCD), the theory of strong interaction. In the early universe, these particles moved (nearly) freely in a quark-gluon plasma.

This is a joint press release of University Muenster and Heidelberg as well as the GSI Helmholtzzentrum für Schwerionenforschung in Darmstadt.

Then, in a phase transition, they combined and formed hadrons, among them the building blocks of atomic nuclei, protons and neutrons. In the current issue of...

Im Focus: Patented nanostructure for solar cells: Rough optics, smooth surface

Thin-film solar cells made of crystalline silicon are inexpensive and achieve efficiencies of a good 14 percent. However, they could do even better if their shiny surfaces reflected less light. A team led by Prof. Christiane Becker from the Helmholtz-Zentrum Berlin (HZB) has now patented a sophisticated new solution to this problem.

"It is not enough simply to bring more light into the cell," says Christiane Becker. Such surface structures can even ultimately reduce the efficiency by...

Im Focus: New soft coral species discovered in Panama

A study in the journal Bulletin of Marine Science describes a new, blood-red species of octocoral found in Panama. The species in the genus Thesea was discovered in the threatened low-light reef environment on Hannibal Bank, 60 kilometers off mainland Pacific Panama, by researchers at the Smithsonian Tropical Research Institute in Panama (STRI) and the Centro de Investigación en Ciencias del Mar y Limnología (CIMAR) at the University of Costa Rica.

Scientists established the new species, Thesea dalioi, by comparing its physical traits, such as branch thickness and the bright red colony color, with the...

Im Focus: New devices based on rust could reduce excess heat in computers

Physicists explore long-distance information transmission in antiferromagnetic iron oxide

Scientists have succeeded in observing the first long-distance transfer of information in a magnetic group of materials known as antiferromagnets.

Im Focus: Finding Nemo's genes

An international team of researchers has mapped Nemo's genome

An international team of researchers has mapped Nemo's genome, providing the research community with an invaluable resource to decode the response of fish to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

"Boston calling": TU Berlin and the Weizenbaum Institute organize a conference in USA

21.09.2018 | Event News

One of the world’s most prominent strategic forums for global health held in Berlin in October 2018

03.09.2018 | Event News

4th Intelligent Materials - European Symposium on Intelligent Materials

27.08.2018 | Event News

 
Latest News

Matter falling into a black hole at 30 percent of the speed of light

24.09.2018 | Physics and Astronomy

NASA balloon mission captures electric blue clouds

24.09.2018 | Earth Sciences

New way to target advanced breast cancers

24.09.2018 | Health and Medicine

VideoLinks
Science & Research
Overview of more VideoLinks >>>